Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Findlow

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Vaccine|May 31, 2015
Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workersJamie Findlow, Xilian Bai, Helen Findlow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidisVictoria Davenport, Terry Guthrie, Jamie Findlow, et al.
Clinical and Vaccine Immunology : CVI|June 1, 2012
Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introductionDavid A Ishola, Ray Borrow, Helen Findlow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
Polysaccharide-specific memory B cells generated by conjugate vaccines in humans conform to the CD27+IgG+ isotype-switched memory B Cell phenotype and require contact-dependent signals from bystander T cells activated by bacterial proteins to differentiate into plasma cellsEdward T Clarke, Neil A Williams, Jamie Findlow, et al.
The Journal of Infection|January 1, 2018
Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and WalesSarah Collins, David Litt, Rachael Almond, et al.
Expert Review of Anti-Infective Therapy|August 7, 2007
On the neisserial vaccine quest: Neisseria Vaccines 2007Rolando Pajón, Olivia Niebla, Daniel Yero, et al.
Clinical and Vaccine Immunology : CVI|October 2, 2008
Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination eraCaroline L Trotter, Ray Borrow, Jamie Findlow, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assayJamie Findlow, Ann Holland, Nick Andrews, et al.
Vaccines|May 27, 2023
Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?Katharina Schley, Jack C Kowalik, Shannon M Sullivan, et al.
Expert Review of Vaccines|April 26, 2022
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverageJamie Findlow, Ray Borrow, David S Stephens, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Vaccine|May 31, 2015
Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workersJamie Findlow, Xilian Bai, Helen Findlow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidisVictoria Davenport, Terry Guthrie, Jamie Findlow, et al.
Clinical and Vaccine Immunology : CVI|June 1, 2012
Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introductionDavid A Ishola, Ray Borrow, Helen Findlow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
Polysaccharide-specific memory B cells generated by conjugate vaccines in humans conform to the CD27+IgG+ isotype-switched memory B Cell phenotype and require contact-dependent signals from bystander T cells activated by bacterial proteins to differentiate into plasma cellsEdward T Clarke, Neil A Williams, Jamie Findlow, et al.
The Journal of Infection|January 1, 2018
Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and WalesSarah Collins, David Litt, Rachael Almond, et al.
Expert Review of Anti-Infective Therapy|August 7, 2007
On the neisserial vaccine quest: Neisseria Vaccines 2007Rolando Pajón, Olivia Niebla, Daniel Yero, et al.
Clinical and Vaccine Immunology : CVI|October 2, 2008
Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination eraCaroline L Trotter, Ray Borrow, Jamie Findlow, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assayJamie Findlow, Ann Holland, Nick Andrews, et al.
Vaccines|May 27, 2023
Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?Katharina Schley, Jack C Kowalik, Shannon M Sullivan, et al.
Expert Review of Vaccines|April 26, 2022
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverageJamie Findlow, Ray Borrow, David S Stephens, et al.
Pageof 10